You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gastric/gastroesophageal junction cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal-junction Cancer Trial (Tcrx T cell)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal-junction Cancer
  • Tcrx T cell
  • (no location specified)
Jul 21, 2022

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (PD-1 inhibitor)

Recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • PD-1 inhibitor
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Aug 9, 2023

Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

Not yet recruiting
  • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
  • XELOX combined with Fruquintinib and Sintilimab
  • (no location specified)
Oct 17, 2023

Locally Advanced Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer Trial in Beijing, Changsha, Shanghai

Recruiting
  • Locally Advanced Gastric Cancer
  • Metastatic HER2 Positive Gastroesophageal Junction Cancer
  • Beijing, Beijing, China
  • +2 more
Feb 21, 2022

Gastric / Gastroesophageal Junction Adenocarcinoma Trial in Shanghai (envafolimab and lenvatinib combined with

Enrolling by invitation
  • Gastric / Gastroesophageal Junction Adenocarcinoma
  • envafolimab and lenvatinib combined with paclitaxel-albumin
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Sep 3, 2023

Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

Not yet recruiting
  • Gastric Cancer
  • S-1, Oxaliplatin, Cadonilimab
  • (no location specified)
Jul 10, 2023

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

Available
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
  • +3 more
  • Morristown, New Jersey
    AMG Hematology/Oncology
Sep 15, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

2D and 3D Primary Cell Cultures From Gastric and

Not yet recruiting
  • Gastric and Gastroesophageal Junction Cancer
    • Berlin, Germany
      Department of Anesthesiology and Operative Intensive Care Medici
    Sep 13, 2022

    Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1

    Active, not recruiting
    • Gastric or Gastroesophageal Junction Adenocarcinoma
    • neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Hospital
    Jul 4, 2023

    HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

    Not yet recruiting
    • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
    • SHR-A1811
    • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
    • (no location specified)
    Nov 6, 2023

    HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

    Not yet recruiting
    • HER2-positive Advanced Gastric Cancer
    • HER2-positive Gastroesophageal Junction Adenocarcinoma
    • Trastuzumab deruxtecan
    • (no location specified)
    Aug 11, 2023

    Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

    Recruiting
    • Adenocarcinoma
    • +8 more
    • Radiotherapy targeted to the primary lesion
    • +7 more
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Nov 7, 2023

    Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)

    No longer available
    • Gastric Cancer
    • Gastroesophageal Junction Adenocarcinoma
    • (no location specified)
    Jan 17, 2023

    Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

    Recruiting
    • Gastric Adenocarcinoma
    • Adenocarcinoma of Gastroesophageal Junction
    • Docetaxel for injection (Albumin-bound)
    • Taxotere
    • Guangzhou, China
      Ethics Committee of Sun-Yat-Sen University Cancer Center
    Jan 27, 2023

    MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer Trial (S095029, Pembrolizumab 200 mg)

    Not yet recruiting
    • MSI-H/dMMR Gastroesophageal-junction Cancer
    • MSI-H/dMMR Gastric Cancer
    • (no location specified)
    Oct 30, 2023

    Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer Trial (T-Dxd(Trastuzmab deruxtecan), Ramucirumab)

    Not yet recruiting
    • Gastric Cancer
    • Gastroesophageal Junction (GEJ) Cancer
    • T-Dxd(Trastuzmab deruxtecan), Ramucirumab
    • (no location specified)
    Jun 7, 2023

    Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Tianjin (Serplulimab+Paclitaxel+Apatinib,

    Recruiting
    • Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jul 5, 2023

    HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811;SHR-1701;capecitabine;oxaliplatin)

    Not yet recruiting
    • HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
    • (no location specified)
    Jan 3, 2023

    Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

    Not yet recruiting
    • Gastric Cancer
    • +3 more
    • LB1908
    • (no location specified)
    Sep 9, 2022

    Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)

    Recruiting
    • Gastric Cancer
    • +3 more
    • Fruquintinib + SOX
    • Nanning, China
      Guangxi Medical University Cancer Hospital
    Dec 2, 2022

    Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer

    Completed
    • Patients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction
    • CT scan
    • (no location specified)
    Sep 13, 2023

    Gastric Cancer Trial (Fruquintinib)

    Not yet recruiting
    • Gastric Cancer
    • (no location specified)
    Oct 17, 2023

    Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

    Not yet recruiting
    • Advanced Esophageal Adenocarcinoma
    • +14 more
    • (no location specified)
    Jan 3, 2023